Understanding Fatty Liver Disease With and Without HIV
Part of Immune system & allergy, Infections clinical trials.
This study examines blood and tissue samples from people with HIV, people without HIV, and healthy volunteers to understand how fatty liver disease develops and progresses. Researchers hope to find new ways to detect and treat fatty liver disease, especially in people living with HIV.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–80 years old
- Able to give written permission and provide blood samples
- For HIV group: diagnosed with HIV, never taken HIV medications, and have fatty liver disease
- For non-HIV group: HIV-negative and have fatty liver disease
- For healthy group: HIV-negative with a normal liver on recent ultrasound
- Not pregnant, not lactating, and no severe liver damage or liver cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to understand the genetic factors behind metabolic fatty liver disease (MASLD) by comparing patients with advanced liver scarring or liver cancer to healthy blood donors. It may help doctors better predict and treat the disease in the future.
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
This study tests whether adding a liver stiffness measurement to a lifestyle program helps people with MASLD (a type of fatty liver disease) improve their liver health. It is designed for people who have fatty liver and at least one sign of metabolic syndrome, like high blood pressure or diabetes.
This study tests if resmetirom can help people who have both HIV and a liver condition called MASLD (fat buildup in the liver not caused by alcohol). You may qualify if your liver has a certain amount of fat and stiffness, and your HIV is well controlled with stable medication.
This study looks at how the liver responds to sugar given through a vein in obese patients with and without a fatty liver condition called MASLD. It may help doctors understand why some people develop liver problems from sugar and fat.
This study tests a new device called LiverScope® that scans your liver to detect fatty liver disease (MASLD). The scan uses special imaging technology and may help doctors diagnose liver disease more quickly and accurately.
Hear when a new MASLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.